TD Asset Management
CRGX

TD Asset Management’s CARGO Therapeutics CRGX Stock Holding History

TD Asset Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-79,644
Closed -$328K – 1245
2025
Q2 		$328K Hold
79,644
– – ﹤0.01% 1154
2025
Q1 		$324K Sell
79,644
-126,584
-61% -$848K ﹤0.01% 1175
2024
Q4 		$2.97M Sell
206,228
-17,062
-8% -$310K ﹤0.01% 898
2024
Q3 		$3.89M Sell
223,290
-66,062
-23% -$1.18M ﹤0.01% 853
2024
Q2 		$4.75M Buy
289,352
+127,418
+79% +$2.42M ﹤0.01% 773
2024
Q1 		$3.61M Buy
+161,934
New +$3.85M ﹤0.01% 848

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TD Asset Management's CRGX Position: Q3 2025 in Review

TD Asset Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 79,644 shares — an estimated $328K sold.

TD Asset Management first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $4.75M in Q2 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • TD Asset Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • TD Asset Management sold 79,644 CARGO Therapeutics shares in Q3 2025, an estimated $328K.
  • TD Asset Management first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
  • TD Asset Management's CARGO Therapeutics position peaked at $4.75M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.